GALLANT 22 Tesaglitazar vs. Placebo

Clinical trial NCT00252837 · TERMINATED

Trial details

NCT number: NCT00252837
Sponsor: AstraZeneca
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

Type 2 Diabetes

Start date: 2005-04-01
Enrollment: 475

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.